~~<i id='B234DC0B8D'><strike id='B234DC0B8D'><tt id='B234DC0B8D'><pre id='B234DC0B8D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

fashion

author：explore 2025-10-01 09:56:03 - browse：8

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： For Medicare Advantage, Democrats want stronger protections around AI

entertainment

Wikipedia

explore

leisure time

hotspot

focus

Asidefromthestethoscope,thearound20-personGliateammanufacturestourniquets,earotoscopes,andcapstostop

WSS

To avoid data mishandling cases, universities eye AI and other tools

What we’ve learned from the Aduhelm mess

Industry veterans launch new biotech VC with $310M

Biden report: The neurospychology of memory and aging

Doctors' information doesn't help them choose wisely when sick

Why did Pfizer dish out millions for a Super Bowl ad?

Wikipedia

fashion

entertainment

Sports medicine is finally prioritizing gender equality

Medicare threatens to cut off funding for HCA's Mission hospital

Virginia high school admissions case could be legal follow

Medicare threatens to cut off funding for HCA's Mission hospital

Malaria cases in Florida and Texas: Here’s what you need to know

Gene therapy’s promise and the high cost of hope

Anesthesiologist group: stop taking Ozempic before surgery

BioAge raises $170M for combination therapy with Zepbound

Peter Hotez and the public health issue of online harassment

Biogen Alzheimer’s drug launch off to slow start

Wikipedia

For Medicare Advantage, Democrats want stronger protections around AI

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Sarepta Duchenne therapy fails to meet primary endpoint in trial

BioAge raises $170M for combination therapy with Zepbound

Readout LOUD podcast: How biotech is using artificial intelligence

Key House Republican on health care plans exit from Congress

explore

leisure time

hotspot

focus